Fang C T, Chang S C, Hsueh P R, Chen Y C, Sau W Y, Luh K T
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
J Formos Med Assoc. 2000 Apr;99(4):300-4.
Community-acquired bacterial meningitis (CABM) is a life-threatening disease that requires prompt initiation of appropriate antibiotic therapy. The purpose of this study was to determine the causative microorganisms of CABM and their antimicrobial susceptibility patterns at a major teaching hospital in Taipei from 1993 to 1998.
A review of medical records and microbiologic data was used to identify cases of CABM and causative pathogens. Antimicrobial susceptibility testing for bacterial isolates was performed by the disk diffusion method.
Among the 48 adult patients with a diagnosis of CABM during the study period, the causative pathogens were identified in 36 cases. Unlike reports from other countries, Klebsiella pneumoniae was the leading causative pathogen (33%), followed by Streptococcus pneumoniae (28%), Listeria monocytogenes (11%), Neisseria meningitidis (6%), Staphylococcus aureus (6%), streptococci (6%), and Pseudomonas aeruginosa (6%). The incidence of CABM due to K. pneumoniae increased during the study period (p = 0.012, Poisson regression), while the incidence of CABM due to other pathogens remained stable. All of the CABM-associated K. pneumoniae isolates were susceptible to cefotaxime but 25% of the CABM-associated S. pneumoniae strains were not susceptible to penicillin G.
Penicillin G alone was not an appropriate empiric therapy for adult CABM because a high percentage of cases were due to K. pneumoniae or penicillin nonsusceptible S. pneumoniae. While the recommendations for the initial empiric regimen for CABM due to S. pneumoniae in Taiwan remain to be developed, third-generation cephalosporins appear to be an appropriate initial empiric regimen for the treatment of CABM due to K. pneumoniae.
社区获得性细菌性脑膜炎(CABM)是一种危及生命的疾病,需要及时开始适当的抗生素治疗。本研究的目的是确定1993年至1998年台北一家主要教学医院中CABM的致病微生物及其抗菌药敏模式。
通过回顾病历和微生物学数据来确定CABM病例和致病病原体。采用纸片扩散法对细菌分离株进行抗菌药敏试验。
在研究期间诊断为CABM的48例成年患者中,36例确定了致病病原体。与其他国家的报告不同,肺炎克雷伯菌是主要致病病原体(33%),其次是肺炎链球菌(28%)、单核细胞增生李斯特菌(11%)、脑膜炎奈瑟菌(6%)、金黄色葡萄球菌(6%)、链球菌(6%)和铜绿假单胞菌(6%)。在研究期间,肺炎克雷伯菌所致CABM的发病率有所增加(p = 0.012,泊松回归),而其他病原体所致CABM的发病率保持稳定。所有与CABM相关的肺炎克雷伯菌分离株对头孢噻肟敏感,但25%与CABM相关的肺炎链球菌菌株对青霉素G不敏感。
单独使用青霉素G并非成人CABM的合适经验性治疗方法,因为相当比例的病例是由肺炎克雷伯菌或对青霉素不敏感的肺炎链球菌引起的。虽然台湾地区针对肺炎链球菌所致CABM的初始经验性治疗方案仍有待制定,但第三代头孢菌素似乎是治疗肺炎克雷伯菌所致CABM的合适初始经验性治疗方案。